Sign in

CIK 0001438533 · Large accelerated filer

Travere Therapeutics, Inc.

Sign in to watch
Ticker
TVTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
CA
Entity type
operating
EIN
262383102
Phone
888-969-7879
Business address
3611 VALLEY CENTRE DR, SUITE 300, SAN DIEGO, CA, 92130
Former names
Retrophin, Inc., Desert Gateway, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$79,812,468
in 11 filings, $79.8M under 10b5-1 plans

Net −$79,812,468. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-05-11 Williams Brinkley Ruth Director Grant or award · Stock option (right to buy) +9,000 9,000
2022-05-11 Squarer Ron Director Grant or award +3,000 17,875
2022-05-11 Squarer Ron Director Grant or award · Stock option (right to buy) +9,000 9,000
2022-05-11 ASELAGE STEVE Director Sale −2,575 $21.92 $56K 146,919
2022-05-11 Poole Sandra Director Grant or award +3,000 12,500
2022-05-11 Poole Sandra Director Grant or award · Stock option (right to buy) +9,000 9,000
2022-05-11 Orwin John A Director Grant or award +3,000 17,875
2022-05-11 Orwin John A Director Grant or award · Stock option (right to buy) +9,000 9,000
2022-05-11 Meckler Jeffrey A Director Grant or award +3,000 70,000
2022-05-11 Meckler Jeffrey A Director Grant or award · Stock option (right to buy) +9,000 9,000
2022-05-11 LYONS GARY A Director Grant or award +3,000 40,000
2022-05-11 LYONS GARY A Director Grant or award · Stock option (right to buy) +9,000 9,000
2022-05-11 COUGHLIN TIMOTHY Director Grant or award +3,000 38,000
2022-05-11 COUGHLIN TIMOTHY Director Grant or award · Stock option (right to buy) +9,000 9,000
2022-05-11 Bruhn Suzanne Louise Director Grant or award +3,000 11,250
2022-05-11 Bruhn Suzanne Louise Director Grant or award · Stock option (right to buy) +9,000 9,000
2022-05-11 Baynes Roy D. Director Grant or award +3,000 20,000
2022-05-11 Baynes Roy D. Director Grant or award · Stock option (right to buy) +9,000 9,000
2022-05-10 REED ELIZABETH E SVP, GC & Corporate Secretary Sale −900 $21.51 $19K 42,888
2022-05-10 Clague Laura Chief Financial Officer Sale −825 $21.51 $18K 37,030

Page 30 of 51 · 1,020 trades